Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
ASLAN004 +1 More for Atopic Dermatitis
Recruiting0 awardsPhase 2
Saint Augustine, Florida
This trial is testing a new medication called ASLAN004 to see if it helps adults with moderate-to-severe Atopic Dermatitis who need stronger treatments. The medication aims to reduce skin inflammation and itching by blocking specific proteins in the immune system.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service